Esperion Therapeutics
ESPR
#7801
Rank
NZ$0.43 B
Marketcap
$2.20
Share price
-4.65%
Change (1 day)
-57.41%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -$4.63

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.04. In 2022 the company made an earnings per share (EPS) of -$6.34 an increase over its 2021 EPS that were of -$17.08.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.63-27.07%
2022-$6.34-62.87%
2021-$17.0880.38%
2020-$9.4750.14%
2019-$6.31-53.18%
2018-$13.477.41%
2017-$12.54110.81%
2016-$5.9547.35%
2015-$4.040.89%
2014-$4.0028.84%
2013-$3.11-89.3%
2012-$29.04
2002-$12.238.89%
2001-$11.23-83.77%
2000-$69.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$18.30 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.39-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.32-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$66.75-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.14-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.21-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA